Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06068829
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-05
First Post:
2023-09-29
Brief Title:
Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders
Sponsor:
Feng Jinzhou
Organization:
First Affiliated Hospital of Chongqing Medical University
Organization Data
Organization:
First Affiliated Hospital of Chongqing Medical University
Class:
OTHER
Study ID:
IRNMO-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Feng Jinzhou
Lead Sponsor Class:
OTHER
Responsible Party:
Feng Jinzhou
Responsible Party Title:
PhD
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
First Affiliated Hospital of Chongqing Medical University
Old Name:
None
Old Organization:
None